作者
Sylvia Adams, Robert J Gray, Sandra Demaria, Lori Goldstein, Edith A Perez, Lawrence N Shulman, Silvana Martino, Molin Wang, Vicky E Jones, Thomas J Saphner, Antonio C Wolff, William C Wood, Nancy E Davidson, George W Sledge, Joseph A Sparano, Sunil S Badve
发表日期
2014/9/9
期刊
Journal of clinical oncology
卷号
32
期号
27
页码范围
2959
出版商
American Society of Clinical Oncology
简介
Purpose
Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (TNBC). We seek to validate the prognostic impact of TILs in primary TNBCs in two adjuvant phase III trials conducted by the Eastern Cooperative Oncology Group (ECOG).
引用总数
2014201520162017201820192020202120222023202478116213416214316216016012361